PEAK Stock Overview
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company.
Healthpeak Properties Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$28.37|
|52 Week High||US$36.85|
|52 Week Low||US$23.23|
|1 Month Change||9.28%|
|3 Month Change||-5.69%|
|1 Year Change||-20.82%|
|3 Year Change||-17.72%|
|5 Year Change||-1.66%|
|Change since IPO||256.02%|
Recent News & Updates
|PEAK||US REITs||US Market|
Return vs Industry: PEAK underperformed the US REITs industry which returned -4.6% over the past year.
Return vs Market: PEAK underperformed the US Market which returned -11.7% over the past year.
|PEAK Average Weekly Movement||4.3%|
|REITs Industry Average Movement||4.3%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||16.9%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: PEAK is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: PEAK's weekly volatility (4%) has been stable over the past year.
About the Company
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
Healthpeak Properties Fundamentals Summary
|PEAK fundamental statistics|
Is PEAK overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PEAK income statement (TTM)|
|Cost of Revenue||US$818.70m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.39|
|Net Profit Margin||10.76%|
How did PEAK perform over the long term?See historical performance and comparison
4.2%Current Dividend Yield
Is PEAK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PEAK?
Other financial metrics that can be useful for relative valuation.
|What is PEAK's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does PEAK's PE Ratio compare to its peers?
|PEAK PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
HR Healthcare Realty Trust
OHI Omega Healthcare Investors
MPW Medical Properties Trust
PEAK Healthpeak Properties
Price-To-Earnings vs Peers: PEAK is expensive based on its Price-To-Earnings Ratio (71.8x) compared to the peer average (69.2x).
Price to Earnings Ratio vs Industry
How does PEAK's PE Ratio compare vs other companies in the US REITs Industry?
Price-To-Earnings vs Industry: PEAK is expensive based on its Price-To-Earnings Ratio (71.8x) compared to the US REITs industry average (32.2x)
Price to Earnings Ratio vs Fair Ratio
What is PEAK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||71.8x|
|Fair PE Ratio||40.6x|
Price-To-Earnings vs Fair Ratio: PEAK is expensive based on its Price-To-Earnings Ratio (71.8x) compared to the estimated Fair Price-To-Earnings Ratio (40.6x).
Share Price vs Fair Value
What is the Fair Price of PEAK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PEAK ($28.37) is trading below our estimate of fair value ($56.26)
Significantly Below Fair Value: PEAK is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Healthpeak Properties forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PEAK's forecast earnings growth (5.7% per year) is above the savings rate (1.9%).
Earnings vs Market: PEAK's earnings (5.7% per year) are forecast to grow slower than the US market (14.4% per year).
High Growth Earnings: PEAK's earnings are forecast to grow, but not significantly.
Revenue vs Market: PEAK's revenue (6.4% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: PEAK's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PEAK's Return on Equity is forecast to be low in 3 years time (4.8%).
Discover growth companies
How has Healthpeak Properties performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PEAK has a large one-off gain of $41.8M impacting its June 30 2022 financial results.
Growing Profit Margin: PEAK became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: PEAK's earnings have declined by 24.1% per year over the past 5 years.
Accelerating Growth: PEAK has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PEAK has become profitable in the last year, making it difficult to compare its past year earnings growth to the REITs industry (52.3%).
Return on Equity
High ROE: PEAK's Return on Equity (3.4%) is considered low.
Discover strong past performing companies
How is Healthpeak Properties's financial position?
Financial Health Score1/6
Financial Health Score 1/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: PEAK's short term assets ($657.4M) do not cover its short term liabilities ($1.7B).
Long Term Liabilities: PEAK's short term assets ($657.4M) do not cover its long term liabilities ($6.6B).
Debt to Equity History and Analysis
Debt Level: PEAK's net debt to equity ratio (91.7%) is considered high.
Reducing Debt: PEAK's debt to equity ratio has reduced from 124.3% to 92.8% over the past 5 years.
Debt Coverage: PEAK's debt is not well covered by operating cash flow (13.7%).
Interest Coverage: PEAK's interest payments on its debt are not well covered by EBIT (2.3x coverage).
Discover healthy companies
What is Healthpeak Properties's current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PEAK's dividend (4.23%) is higher than the bottom 25% of dividend payers in the US market (1.49%).
High Dividend: PEAK's dividend (4.23%) is in the top 25% of dividend payers in the US market (4%)
Stability and Growth of Payments
Stable Dividend: PEAK's dividend payments have been volatile in the past 10 years.
Growing Dividend: PEAK's dividend payments have fallen over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (72.6%), PEAK's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (74.1%), PEAK's dividend payments are covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Tom Herzog (59 yo)
Mr. Thomas M. Herzog, also known as Tom, has been the Chief Executive Officer and Non-Independent Director of Healthpeak Properties, Inc. since January 1, 2017 and served as its President from January 1, 2...
CEO Compensation Analysis
Compensation vs Market: Tom's total compensation ($USD11.71M) is about average for companies of similar size in the US market ($USD12.88M).
Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.
Experienced Management: PEAK's management team is seasoned and experienced (5 years average tenure).
Experienced Board: PEAK's board of directors are considered experienced (7.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Healthpeak Properties, Inc.'s employee growth, exchange listings and data sources
- Name: Healthpeak Properties, Inc.
- Ticker: PEAK
- Exchange: NYSE
- Founded: 1985
- Industry: Health Care REITs
- Sector: Real Estate
- Implied Market Cap: US$15.511b
- Market Cap: US$15.308b
- Shares outstanding: 546.91m
- Website: https://www.healthpeak.com
Number of Employees
- Healthpeak Properties, Inc.
- 5050 South Syracuse Street
- Suite 800
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/12 00:00|
|End of Day Share Price||2022/08/12 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.